LivaNova PLC (LIVN)

Compare

39.03

-0.25

(-0.64%)

At close: 4:00:01 PM EDT

39.03

0.00

(0.00%)

After hours: 4:05:06 PM EDT

LivaNova to Announce First-Quarter 2025 Results

LONDON, March 26, 2025--LivaNova PLC will host a conference call to discuss its first-quarter 2025 results on Wed., May 7, 2025, at 1 p.m. London time (8 a.m. Eastern Time).

Business Wire 6 days ago

LIVN
-0.64%
LivaNova (NASDAQ:LIVN) investors are sitting on a loss of 50% if they invested three years ago

As an investor its worth striving to ensure your overall portfolio beats the market average. But in any portfolio...

Simply Wall St. 7 days ago

LIVN
-0.64%
LivaNova's (NASDAQ:LIVN) Performance Is Even Better Than Its Earnings Suggest

Investors were underwhelmed by the solid earnings posted by LivaNova PLC ( NASDAQ:LIVN ) recently. Our analysis says...

Simply Wall St. 27 days ago

LIVN
-0.64%
Is LivaNova PLC (LIVN) the Best Medical Technology Stock to Buy According to Analysts?

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are going to take a look at where LivaNova PLC (NASDAQ:LIVN) stands against the other medical technology stocks. Growth and Drivers of the Global MedTech Market The MedTech sector is crucial in healthcare, which concentrates […]

Insider Monkey 27 days ago

LIVN
-0.64%
LivaNova PLC Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

It's been a mediocre week for LivaNova PLC ( NASDAQ:LIVN ) shareholders, with the stock dropping 15% to US$40.93 in the...

Simply Wall St. last month

LIVN
-0.64%
LivaNova Full Year 2024 Earnings: EPS Beats Expectations

LivaNova ( NASDAQ:LIVN ) Full Year 2024 Results Key Financial Results Revenue: US$1.25b (up 8.7% from FY 2023). Net...

Simply Wall St. last month

LIVN
-0.64%
LivaNova PLC (LIVN) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...

LivaNova PLC (LIVN) reports robust organic revenue growth and strategic advancements, despite challenges in international markets and earnings per share decline.

GuruFocus.com last month

LIVN
-0.64%
LivaNova (LIVN) Tops Q4 Earnings Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of 1.25% and 0.48%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

LIVN
-0.64%
LivaNova: Q4 Earnings Snapshot

The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 80 cents per share. The medical technology company posted revenue of $321.8 million in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $323.4 million.

Associated Press Finance last month

LIVN
-0.64%
LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance

LONDON, February 25, 2025--LivaNova PLC today reported fourth-quarter and full-year 2024 results and issued full-year 2025 guidance.

Business Wire last month

LIVN
-0.64%
Getinge’s surgical perfusion market exit ‘opens door’ for LivaNova

Getinge is phasing out its surgical perfusion business to focus on the ECMO market.

Medical Device Network last month

GNGBY

LIVN
-0.64%
GLDAF
LivaNova to Present at the Barclays Global Healthcare Conference

LONDON, February 21, 2025--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Barclays Global Healthcare Conference in Miami, Florida. The presentation will take place at 2:00 p.m. Eastern Time on Tuesday, March 11.

Business Wire last month

LIVN
-0.64%
Getinge plans to leave surgical perfusion

The company will re-allocate resources and focus on more lucrative areas with higher growth potential.

Medical Device Network last month

GNGBY

LIVN
-0.64%
Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Simply Wall St. last month

LIVN
-0.64%
Should You Sell LivaNova PLC (LIVN)?

Greenlight Capital, an investment management firm, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In 2024, the Greenlight Capital funds returned 7.2% net of fees and expenses, compared to 25.0% for the S&P 500 index. The Partnerships have returned 3,117% cumulatively or 12.9% annualized both net of fees and […]

Insider Monkey 2 months ago

LIVN
-0.64%
GLRE
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results

LONDON, January 21, 2025--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its fourth-quarter and full-year 2024 results on Tuesday, February 25, 2025 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its fourth-quarter and full-year 2024 results prior to the call.

Business Wire 2 months ago

LIVN
-0.64%
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer

LONDON, January 06, 2025--LivaNova PLC today announced that Natalia Kozmina is joining the Company as Chief Human Resources Officer (CHRO), effective January 14.

Business Wire 2 months ago

LIVN
-0.64%
5 Beaten-Down MedTech Stocks Set to Rebound in 2025

Investors may want to take a closer look at discounted stocks, such as MCK, HAE, ARAY, LIVN and PBH, in the present market landscape.

Zacks 2 months ago

HAE

LIVN
-0.64%
ARAY
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression

LONDON, December 18, 2024--LivaNova PLC announced that Brain Stimulation published two pivotal articles chronicling the unipolar cohort data set for the RECOVER clinical study.

Business Wire 3 months ago

LIVN
-0.64%
LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting

LONDON, December 05, 2024--LivaNova PLC today announced its participation in the American Epilepsy Society (AES) 2024 Annual Meeting, taking place Dec. 6-10 in Los Angeles.

Business Wire 3 months ago

LIVN
-0.64%

Performance Overview

Return	LIVN	S&P 500 (^GSPC)
YTD	-15.72%	-4.23%
1-Year	-29.24%	+7.42%
3-Year	-53.93%	+23.92%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

LivaNova PLC (LIVN)

LivaNova to Announce First-Quarter 2025 Results

LivaNova (NASDAQ:LIVN) investors are sitting on a loss of 50% if they invested three years ago

LivaNova's (NASDAQ:LIVN) Performance Is Even Better Than Its Earnings Suggest

Is LivaNova PLC (LIVN) the Best Medical Technology Stock to Buy According to Analysts?

LivaNova PLC Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

LivaNova Full Year 2024 Earnings: EPS Beats Expectations

LivaNova PLC (LIVN) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...

LivaNova (LIVN) Tops Q4 Earnings Estimates

LivaNova: Q4 Earnings Snapshot

LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance

Getinge’s surgical perfusion market exit ‘opens door’ for LivaNova

LivaNova to Present at the Barclays Global Healthcare Conference

Getinge plans to leave surgical perfusion

Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up

Should You Sell LivaNova PLC (LIVN)?

LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results

LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer

5 Beaten-Down MedTech Stocks Set to Rebound in 2025

RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression

LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting

Performance Overview